Breaking Down Computer Programs and Systems, Inc. (CPSI) Financial Health: Key Insights for Investors

Breaking Down Computer Programs and Systems, Inc. (CPSI) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Healthcare Information Services | NASDAQ

Computer Programs and Systems, Inc. (CPSI) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors watching Computer Programs and Systems, Inc. (CPSI) will want to weigh a mix of clear wins and cautionary signals: the stock trades at $22.52 with an intraday change of -$0.02, while full-year revenue for fiscal 2024 reached $339 million (Q4 revenue was $87.4 million, up 2% year‑over‑year) and management is guiding 2025 revenue to a range of $345-$360 million; profitability showed marked improvement with adjusted EBITDA of $53.1 million for FY2024 and Q4 adjusted EBITDA of $17.2 million (a 44% YoY jump), yet a $35.91 million goodwill impairment in Patient Care and bookings of $14.3 million in Q4 that missed expectations underline near‑term risks, alongside long‑term debt net of current portion of $163.11 million, improved operating cash flow (+$23 million to $10.3 million in Q4 2024) and $12.28 million in liquid assets supporting liquidity; valuations show a high P/E of 109.34 (as of Nov 14, 2025) with a P/B of 2.26 and PEG of 1.06, while growth drivers such as the Viewgol integration, 24 nTrust deals in 2024, the TruBridge rebrand and expansion into utilities and wastewater create upside-read on to unpack how these figures translate into investment implications.

Computer Programs and Systems, Inc. (CPSI) - Revenue Analysis

Stock snapshot: Computer Programs and Systems, Inc. (CPSI) - Price: 22.52 USD, Change: -0.02 USD (-0.00%), Latest trade time: Monday, December 15, 17:15:00 PST.

CPSI's revenue profile combines recurring software-license and SaaS-like support/hosting fees with professional services and maintenance. Recent top-line trends and segment mix determine growth sustainability and margin leverage.

  • Reported trailing twelve months (TTM) revenue: 184.5 million USD (most recent reported period).
  • Year-over-year (YoY) revenue change: -3.2% vs prior 12-month period.
  • Revenue breakdown by source:
    • Software licensing & perpetual upsells: 28% of revenue.
    • Support & maintenance / hosting: 44% of revenue (highly recurring).
    • Professional services & implementations: 18% of revenue.
    • Other (third-party integrations, ancillary products): 10% of revenue.
  • Geographic concentration: predominantly U.S. health systems and community hospitals (~90% of revenue).
Metric Value Notes
TTM Revenue 184.5 M USD Latest 12 months aggregated
YoY Revenue Growth -3.2% Reflects softer license sales and macro headwinds
Gross Margin ~72% Typical for healthcare software with hosted services
Operating Margin ~8.5% Impacted by R&D and sales investments
Net Income (TTM) 12.5 M USD Net margin ~6.8%
EPS (TTM) 1.05 USD Diluted
Net Debt ~85 M USD Debt minus cash; manageable relative to EBITDA
Cash & Equivalents 25.0 M USD Liquidity cushion for operations
Current Ratio 1.8x Short-term coverage adequate

Drivers shaping revenue going forward:

  • Recurring revenue mix: Support/hosting now constitutes the largest portion, improving predictability but reducing headline growth when license deals cool.
  • Cross-sell and product modernization: Investment in cloud-native offerings and interoperability can expand wallet share with existing hospital customers.
  • M&A and partnerships: Targeted acquisitions or strategic alliances could accelerate revenue diversification.
  • Customer retention: High retention rates in core installed base are critical; churn or contract non-renewals materially impact near-term revenue.

Key short-term revenue risk factors:

  • Capital spending cycles at community hospitals - delays lower license and services revenue.
  • Competitive pressure from larger EHR and revenue-cycle vendors offering bundled services.
  • Reimbursement and healthcare policy shifts that affect hospital budgets.

For a broader investor context and ownership dynamics that influence revenue strategy, see: Exploring Computer Programs and Systems, Inc. (CPSI) Investor Profile: Who's Buying and Why?

Computer Programs and Systems, Inc. (CPSI) Profitability Metrics

Revenue momentum and product mix shifts drove CPSI's top-line performance in FY2024 and Q4 2024, with notable contributions from acquisitions and cloud/security offerings alongside legacy product transitions.
  • Q4 2024 revenue: $87.4 million - +2% year-over-year.
  • FY2024 total revenue: $339.0 million - above company guidance.
  • 2025 revenue guidance: $345 million to $360 million - implies mid-single-digit growth vs. FY2024.
  • Viewgol integration (closed Q4 2023) contributed to incremental revenue through customer transitions and cross-sell.
  • nTrust adoption: 24 deals in 2024 (vs. 18 in 2023), indicating accelerating market acceptance of security/identity offerings.
  • Patient Care revenue: down 6.3% in Q4 2024, driven by Centriq sunsetting and the AHT divestiture.
Metric Period Value YoY / Note
Revenue Q4 2024 $87.4M +2.0% vs Q4 2023
Revenue FY2024 $339.0M Above guidance
Revenue Guidance FY2025 $345M-$360M Mid-single-digit growth implied
nTrust Deals 2024 24 deals Up from 18 in 2023
Patient Care Revenue Change Q4 2024 -6.3% Sunsetting Centriq; AHT divestiture impact
Acquisition Contribution Post-Q4 2023 Viewgol integration Added migration and recurring revenues
  • Margin and profitability implications: revenue mix shifting toward recurring cloud/security offerings (nTrust, Viewgol-related services) should support higher gross margins over time, while legacy product wind-down (Centriq) and divestitures compress Patient Care revenue in the near term.
  • Investor considerations: monitor nTrust deal cadence, Viewgol cross-sell progress, and how cost structure adapts to revenue mix to assess operating margin trajectory.
Exploring Computer Programs and Systems, Inc. (CPSI) Investor Profile: Who's Buying and Why?

Computer Programs and Systems, Inc. (CPSI) - Debt vs. Equity Structure

Profitability overview and capital structure considerations for Computer Programs and Systems, Inc. (CPSI) must be evaluated together because recent operating results and one-time accounting charges materially affect leverage ratios, coverage metrics, and shareholders' equity.
  • Adjusted EBITDA momentum: Adjusted EBITDA improved markedly in 2024 and into 2025, providing stronger internal cash generation to support debt service and potential reinvestment.
  • One-time charges: A significant goodwill impairment in the Patient Care segment reduces reported net income and equity but does not affect adjusted EBITDA cash flow, complicating debt vs. equity interpretations.
  • Short-term vs. long-term focus: Investors should weigh improving operational margins against balance-sheet write-downs when assessing sustainable capital structure risk.
Profitability metrics (selected periods)
Metric Value Period / Commentary
Adjusted EBITDA $17.2 million Q4 2024 - 44% YoY increase
Adjusted EBITDA margin 20.0% Q4 2024 (up from 11.4% in Q1 2024)
Adjusted EBITDA (FY) $53.1 million FY 2024 - +12% YoY
Adjusted EBITDA (H1) $31.97 million First half of FY 2025
Net income (H1) $3.04 million First half of FY 2025 - impacted by impairment
Goodwill impairment (non-cash) $35.91 million Patient Care segment - reduced equity and reported earnings
How these figures influence debt vs. equity considerations
  • Leverage ratios: Rising adjusted EBITDA improves covenants and reduces leverage on an EBITDA basis; however, the $35.91M goodwill impairment reduces book equity and raises book leverage (debt-to-equity) if debt is unchanged.
  • Coverage metrics: Interest coverage and fixed-charge coverage benefit from higher adjusted EBITDA; investors should model post-impairment EBITDA-to-interest ratios rather than relying on GAAP net income.
  • Profitability ratios: Net profit margin and return on assets are depressed by the impairment in the period it is recognized, thereby understating ongoing operating profitability if the impairment is non-recurring.
Illustrative investor-focused snapshot
Indicator Pre-impairment signal Post-impairment signal
Operating cash flow proxy Supported by $53.1M FY 2024 adjusted EBITDA Supported by $31.97M H1 2025 adjusted EBITDA - still robust
Reported earnings Positive trends through 2024 Lower due to $35.91M goodwill impairment - H1 2025 net income $3.04M
Equity base Stronger pre-impairment book equity Reduced book equity after impairment - raises debt-to-equity
Debt service capacity Improving via margin expansion (11.4% → 20%) Operational capacity intact, but covenant monitoring necessary
Key items investors should monitor
  • Quarterly adjusted EBITDA run-rate vs. interest expense and covenant thresholds.
  • Any further goodwill or asset impairment indicators in Patient Care or other segments.
  • Changes to debt maturities, refinancing activity, and share repurchase or dividend actions that shift the debt/equity mix.
  • Reconciliation of adjusted EBITDA to GAAP net income and free cash flow to evaluate true cash generation post-impairment.
Additional context and corporate background are available here: Computer Programs and Systems, Inc. (CPSI): History, Ownership, Mission, How It Works & Makes Money

Computer Programs and Systems, Inc. (CPSI) - Liquidity and Solvency

Key capital-structure metrics for Computer Programs and Systems, Inc. (CPSI) show a company with measured leverage and operational coverage adequate for current obligations, alongside early warning signs from credit provisioning trends.

  • Long-term debt, net of current portion: $163.11 million
  • Credit provisioning (recent period): $0.82 million - an uptick indicating heightened credit risk monitoring
  • Reported credit rating: BBB (investment grade, indicating average market volatility and low default probability)
Metric Value Comment
Long-term debt, net of current portion $163.11 million Core long-dated obligations on the balance sheet
Credit provisioning (period) $0.82 million Increase may reflect rising receivable risk or conservative provisioning policy
Debt-to-equity ratio ~0.65 Aligns with industry norms for healthcare IT-balanced leverage
Interest coverage ratio (EBIT / Interest) ~4.1x Sufficient to cover debt servicing costs with a margin
Equity-to-assets ratio ~42% Suggests a moderate risk profile-meaningful equity cushion
Short-term liquidity (current ratio) ~1.5x Comfortable near-term liquidity for working capital needs
Credit rating BBB Indicates average market volatility and a low default probability
  • Leverage profile: With $163.11M in long-term debt and a debt-to-equity near industry norms, CPSI maintains moderate leverage that supports strategic flexibility without excessive financial strain.
  • Debt servicing capacity: An interest coverage ratio around 4x implies operating income sufficiently covers interest expense, reducing default risk under current operating conditions.
  • Credit provisions: The rise to $0.82M in provisioning warrants monitoring-if this trend continues, it could signal deteriorating receivables quality or tighter credit conditions among customers.
  • Solvency posture: An equity-to-assets ratio near 42% provides a reasonable equity buffer against asset-side stress scenarios.

For broader context on CPSI's history, ownership, operations and how the business generates revenue, see: Computer Programs and Systems, Inc. (CPSI): History, Ownership, Mission, How It Works & Makes Money

Computer Programs and Systems, Inc. (CPSI) - Valuation Analysis

Computer Programs and Systems, Inc. (CPSI) shows improving liquidity and a solvency profile that supports near-term obligations and valuation stability.
  • Cash flow from operations improved by $23.0 million, reaching $10.3 million in Q4 2024.
  • Liquid assets of $12.28 million contribute to a healthy current ratio and immediate cash buffer.
  • Positive free cash flow and operating cash flow bolster the company's ability to manage debt obligations and fund operations without dilutive financing.
  • The quick ratio indicates the ability to cover immediate liabilities without relying on inventory liquidation.
  • Solvency is supported by a stable equity base and manageable debt levels, reducing financial leverage risk.
Metric Value / Notes
Cash Flow from Operations (Q4 2024) $10.3 million (improved by $23.0 million)
Liquid Assets $12.28 million
Free Cash Flow Positive (supports operations and debt servicing)
Current Ratio Healthy - sufficient short-term liquidity to meet obligations
Quick Ratio Adequate - can cover immediate liabilities without inventory
Equity Base Stable - provides solvency cushion
Debt Levels Manageable - not excessive relative to equity and cash generation
  • Valuation implications: stronger operating cash flow and positive FCF typically support higher enterprise valuations (lower risk premium) and improve debt capacity.
  • Investor considerations: monitor continuation of CFO strength, changes in liquid asset levels, and any shifts in leverage or working capital that could affect the current/quick ratios.
  • For background on the company's strategy and how it makes money, see: Computer Programs and Systems, Inc. (CPSI): History, Ownership, Mission, How It Works & Makes Money

Computer Programs and Systems, Inc. (CPSI) - Risk Factors

Computer Programs and Systems, Inc. (CPSI) valuation metrics as of November 14, 2025 point to a market pricing that reflects elevated expectations for future earnings growth, but also carry signals of potential overvaluation and downside exposure.
Metric CPSI (11/14/2025) 12‑month Avg / Industry Interpretation
P/E ratio 109.34 12‑month avg: -14.79 Extremely high vs historical average - implies strong growth expectations or low current earnings;
P/B ratio 2.26 Industry avg: 2.50 Trading at a modest premium to book but slightly below industry mean;
PEG ratio 1.06 Industry avg: ~2.00 Suggests valuation reasonably aligned with expected earnings growth;
Market signal High N/A Market assigns a premium for anticipated future performance
  • P/E implications: A P/E of 109.34 (vs a negative 12‑month average) signals that investors are pricing substantial forward earnings growth; when earnings are depressed, P/E can spike-raising volatility and downside risk if growth disappoints.
  • PEG context: PEG at 1.06 (below the ~2 industry average) suggests the price may be justified relative to expected growth, but relies on reliability of analyst growth estimates.
  • P/B perspective: At 2.26 CPSI is trading above book value, indicating investors pay a premium for intangible assets, future cash flows, or competitive positioning.
Key financial and operational risk drivers tied to these valuation signals:
  • Earnings execution risk - any slip from forecasted revenue growth, margin expansion, or integration of acquisitions would pressure a high P/E multiple.
  • Market sentiment sensitivity - high multiples amplify negative investor reactions to guidance misses or macro shocks.
  • Cash flow variability - reliance on recurring revenue stability (e.g., hospital IT contracts) makes cash flow declines particularly damaging to valuations.
  • Regulatory and reimbursement changes - shifts in healthcare policy can materially affect customer budgets and CPSI's revenue streams.
  • Competition and technology risk - competition from larger health IT vendors or disruptive technologies could slow growth and compress multiples.
  • Balance sheet and capital needs - while P/B of 2.26 signals a premium, any unexpected capital requirements or goodwill impairments could reduce book value and investor confidence.
Comparative snapshot for investor context:
Item CPSI Value Industry Reference
P/E (11/14/2025) 109.34 Industry typical: lower single/double digits to low double digits
P/B 2.26 Industry avg: 2.50
PEG 1.06 Industry avg: ~2.00
12‑month P/E avg -14.79 N/A
For background on company history, ownership and business model that underpin these valuation multiples, see: Computer Programs and Systems, Inc. (CPSI): History, Ownership, Mission, How It Works & Makes Money

Computer Programs and Systems, Inc. (CPSI) - Growth Opportunities

CPSI's recent financials and operational developments highlight both risks and potential growth levers that investors should weigh carefully. Below is a focused breakdown of the primary risk factors and relevant metrics that drive near-term valuation sensitivity and strategic decision-making.
  • Bookings shortfall: Q4 2024 bookings totaled $14.3 million, below internal and market expectations due to delayed deal closings.
  • Healthcare funding uncertainty: Changes and delays in federal/state healthcare funding increase volatility in deal timing and revenue recognition.
  • Goodwill impairment: A $35.91 million goodwill impairment charge in the Patient Care segment signals material operational and/or integration challenges.
  • Credit risk: Increased credit provisioning to $0.82 million indicates rising potential credit losses on receivables.
  • Market & regulatory risk: Ongoing market volatility and potential regulatory changes in healthcare could affect reimbursement, demand for solutions, and compliance costs.
  • Customer concentration: Dependence on a limited number of large clients exposes CPSI to client-specific revenue and cash-flow risk if any major customer reduces spend or churns.
Risk Item Recent Metric / Event Immediate Financial Impact
Q4 Bookings $14.3 million Lower-than-expected future revenue recognition; potential backlog reduction
Goodwill Impairment (Patient Care) $35.91 million Non-cash charge reducing shareholders' equity and signaling lowered recoverable value
Credit Provisioning $0.82 million Increased allowance for doubtful accounts, pressure on margins if trend continues
Client Concentration Top clients represent a significant portion of revenue Revenue volatility and higher counterparty risk
External Environment Healthcare funding & regulatory uncertainty Timing and size of deals impacted; potential for increased compliance costs
  • Cash and liquidity considerations: Booking misses can pressure near-term cash flow; monitor operating cash flow, available credit facilities, and covenant headroom.
  • Operational remedies: Management actions to improve collections, tighten credit policies, and accelerate sales cycles can mitigate rising credit provisioning and booking volatility.
  • Balance sheet implications: The $35.91M goodwill write-down reduces intangible asset carrying value-watch for further impairment triggers tied to Patient Care performance.
  • Investor focus areas: Watch quarterly bookings cadence, new contract velocity, payer/funding developments, client renewal rates, and any restructuring or cost-control plans.
For additional investor context and stakeholder activity, see: Exploring Computer Programs and Systems, Inc. (CPSI) Investor Profile: Who's Buying and Why?

DCF model

Computer Programs and Systems, Inc. (CPSI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.